Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,589 public trials 1,039 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Active, Not Recruiting

Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer

NCT02912572

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

NCT06182241

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cervical Cancer, +26 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston University Boston, Massachusetts, United States
  • MatCH Research Unit (MRU), a Division of the Wits Health Consortium, University of Witwatersrand Durban, KwaZulu-Natal, South Africa
View Trial Details
Active, Not Recruiting

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
Locations
  • Massachusetts General Hospital - Boston Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Mount Sinai Tisch Cancer Center New York, United States
  • NEXT Oncology - Dallas Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

NCT02264678

Conditions
Adnexal Diseases, Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer, Endocrine Gland Neoplasms, +13 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

NCT04634877

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • University of Alabama - Birmingham ( Site 3061) Birmingham, Alabama, United States
  • University of South Alabama, Mitchell Cancer Institute ( Site 3058) Mobile, Alabama, United States
  • HonorHealth Research Institute - Biltmore ( Site 3043) Phoenix, Arizona, United States
  • Arizona Oncology Associates PC- HOPE ( Site 3049) Tucson, Arizona, United States
View all 231 locations
View Trial Details
Active, Not Recruiting

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

NCT02298959

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +60 more
Locations
  • Moffitt Cancer Center-International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
View Trial Details
Active, Not Recruiting

ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer

NCT05653063

Conditions
Cancer Cervix, Cancer Head Neck, Cancer Of Prostate, +19 more
Locations
  • Tata Medical Centre Kolkata, India
  • Tata Memorial Hospital Mumbai, India
  • King Hussein Cancer Center Amman, Jordan
  • University of Malaya Medical Center Kuala Lumpur, Malaysia
View Trial Details
Active, Not Recruiting

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

NCT06003231

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Gilbert, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Glendale, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Mesa, Arizona, United States
View all 96 locations
View Trial Details

Related conditions